Covance Inc (CVD)
CVD on New York Consolidated
76.45USD
20 May 2013
76.45USD
20 May 2013
Price Change (% chg)
$-0.88 (-1.14%)
$-0.88 (-1.14%)
Prev Close
$77.33
$77.33
Open
$77.15
$77.15
Day's High
$77.38
$77.38
Day's Low
$76.31
$76.31
Volume
161,136
161,136
Avg. Vol
395,400
395,400
52-wk High
$78.36
$78.36
52-wk Low
$44.19
$44.19
About
Covance Inc. is a drug development services company providing a range of early-stage and late-stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries. The Company also provides laboratory testing services to the chemical, agrochemical and food... (more)
Overall
| Beta: | 1.14 |
| Market Cap (Mil.): | $4,321.21 |
| Shares Outstanding (Mil.): | 55.88 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CVD | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 40.26 | 53.78 | 35.83 |
| EPS (TTM): | 1.92 | -- | -- |
| ROI: | 7.70 | 1.00 | 18.72 |
| ROE: | 8.31 | 2.10 | 19.54 |
Competitors
| Price | Change | |
|---|---|---|
| Charles River Laboratories (CRL.N) | $44.91 | -0.10 |
| PAREXEL International Corporation (PRXL.OQ) | $46.57 | -0.14 |
| ICON plc (ICON.I) | -- | -- |
| Quest Diagnostics Inc (DGX.N) | $60.80 | +0.11 |
| WuXi PharmaTech (Cayman) Inc. (ADR) (WX.N) | $20.76 | +0.33 |
| Quintiles Transnational (QTRN.BE) | -- | -- |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Trading Report for (CVD). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$115.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

